Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
0 hedge funds and large institutions have $0 invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.
100% less funds holding
Funds holding: 9 → 0 (-9)
100% less capital invested
Capital invested by funds: $97.3K → $0 (-$97.3K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VFA
Values First Advisors
Gray,
Tennessee
|
-$41.2K |
| 2 |
Renaissance Technologies
New York
|
-$35K |
| 3 |
AWM
Activest Wealth Management
Aventure,
Florida
|
-$9.76K |
| 4 |
Morgan Stanley
New York
|
-$8.08K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3.12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VFA
1
Values First Advisors
Gray,
Tennessee
| – | -$41.2K | -27,262 | Closed |
|
|
2
Renaissance Technologies
New York
| – | -$35K | -22,861 | Closed |
|
|
3
Morgan Stanley
New York
| – | -$8.08K | -5,351 | Closed |
|
|
4
Osaic Holdings
Scottsdale,
Arizona
| – | -$3.12K | -2,008 | Closed |
|
5
Bank of America
Charlotte,
North Carolina
| – | -$127 | -84 | Closed |
|
6
Wells Fargo
San Francisco,
California
| – | -$60 | -40 | Closed |
|
|
AWM
7
Activest Wealth Management
Aventure,
Florida
| – | -$9.76K | -13 | Closed |
|
|
AA
8
Addison Advisors
Middlebury,
Vermont
| – | -$13 | -8 | Closed |
|
NBRV Hedge Fund Activity: Q3 2023 in Review
0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q3 2023, worth a combined $0 — down 100% from $97.3K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NBRV and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Values First Advisors, exiting entirely with an estimated $41.2K sold.
- 0 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q3 2023, down from 9 in Q2 2023.
- Funds reported $0 of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q3 2023 and 9 closed out, a net change of -9 holders.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q3 2023 was Values First Advisors, an estimated $41.2K sold.
Based on aggregated 13F filings for Q3 2023.